Recombinant respiratory syncytial virus vaccine( (CHO Cell) (Xiamen Innovax Biotech)

重组呼吸道合胞病毒疫苗（CHO细胞）（厦门万泰沧海生物）

Report date: 2026/03/12 14:53:16

Base Information

Drug NameRecombinant respiratory syncytial virus vaccine( (CHO Cell) (Xiamen Innovax Biotech)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesXiamen Innovax Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiamen Innovax Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A